Cambridge, UK: EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect. Colin’s appointment will support the next phase of the Company’s development and the commercialisation of its semiconductor-based DNA synthesis platform. Colin brings over 20 years’ experience in commercial and […]

SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Joydeep Goswami, Chief Strategy and Corporate Development Officer, will also serve as interim Chief Financial Officer while the company conducts a search for a permanent CFO. Sam Samad will be departing Illumina on July 8, 2022, after serving […]

SAN DIEGO – Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced the appointment of Jeffrey R. Sampson, Ph.D., to its Board of Directors. Dr. Sampson is an Associate Vice President and Research Fellow for Agilent Technologies, where he contributes at the interface of technology, intellectual property, and business strategy. […]

The leader in R&D scientific software adds Chief Legal Officer and Chief People Officer BOSTON – June 6, 2022 — Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, today announced the addition of Larry Samuelson as Chief Legal Officer and Neil Frye as Chief People Officer. The appointments further bolster the […]

BILLERICA, Mass. — Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Karen A. Flynn, Senior Vice President and Chief Commercial Officer of Catalent Pharma Solutions (NYSE: CTLT), has been appointed to Quanterix’ Board of Directors effective June 6, 2022. Ms. Flynn is […]

With the beginning of the new fiscal year 2022, LINSEIS Messgeräte GmbH expands its management. The two sons of the former sole managing director Claus Linseis, Florian Linseis, Master of Science, and Vincent Linseis, Doctor of Engineering, have already been supporting the family business for many years and have now been appointed as management. The […]

Carl Zeiss AG is expanding its Executive Board team with Susan-Stefanie Breitkopf as Chief Transformation Officer. She is currently Head of Corporate Human Resources at the ZEISS Group. Dr. Matthias Metz, member of the Executive Board of Carl Zeiss AG and responsible for the ZEISS Consumer Markets segment, will switch to BSH Hausgeräte GmbH, Munich. […]

Hein to lead as SCIENION plans for long-term profitable growth BERLIN. SCIENION GmbH, a BICO company and the precision liquid handling technology company powering life sciences and diagnostics for the future of health, today appointed Dr. Frauke Hein as co-Chief Executive Officer (CEO) alongside current CEO Dr. Holger Eickhoff, effective immediately. Hein and Eickhoff will […]

WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of Konstantin Konstantinov, Ph.D., a life sciences and bioprocessing industry expert. Dr. Konstantinov brings to the director role nearly 30 years of relevant experience, including his current position as Chief Technology Officer at Codiak BioSciences, where he previously served for […]

FOSTER CITY, Calif. — Illumina Ventures, today announced the promotion of Malek Faham, MD, PhD, to Chief Scientist having previously served as both a Venture Partner and Entrepreneur in Residence (EIR). In addition, Charles Lin, PhD, has joined the team as a Principal, and Dave Johnson, PhD, has joined as an Entrepreneur in Residence. “Having […]